How do you interpret the potential for cure in patients with dMMR/MSI-H advanced or recurrent endometrial cancer in light of the recently presented long-term survival and cure modeling data?
Are you factoring cure potential into treatment duration and patient counseling decisions?
Powell et al. DOI: 10.1200/JCO.2026.44.16_suppl.5501
Community PollStarted
Are you using the words "cure" or "curable" when counseling women with newly diagnosed advanced dMMR endometrial cancer?
33 physicians have voted
Join Mednetto vote and see how they answered.